Nabriva
formerly Nabriva TherapeuticsNabriva was founded in 2005, is headquartered in Vienna, Austria, and has $142.0M in recorded funding across 2 rounds.
- Headquarters
- Vienna
- Founded
- 2005
- Business Model
- B2B
- Website
- nabriva.com
- Total Funding
- $142.0M
- Last Round
- $120.0M Series BApr 2015
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 9 investors for this company. The full record is or through the API.
About
A commercial-stage biopharmaceutical company developing novel antibiotics to treat serious infections.
Summary
Nabriva is a Biotech company based in Vienna, Austria, founded in 2005. It has raised $142.0M in total across 2 rounds, most recently a $120.0M Series B round in Apr 2015. Investors include Vivo Capital, OrbiMed and Novartis Venture Fund.
Funding History
Apr 2015
Sign up to see all 2 events
Funding: Venture Round through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nabriva"><img src="https://indexed.vc/api/badge/company/nabriva" alt="Nabriva on Indexed.vc" width="260" height="76" /></a>